(Academy of Intellectual Property Studies) is conducting an one-day seminar on 15th July, 2011 on "Section 3(d): Proof of Efficacy". The seminar will deal with issues relating to proving efficacy under the Indian Patents Act, 1970 based on the decisions that have come out of the Patent Office and the High Courts. I will be the main speaker for the day. Details of the program are available here
The right to appeal of a patent applicant whose application is rejected persuant to a pre-grant opposition has been illusory at best. For a legal mind, it is unthinkable to envisage a situation where the first order becomes the final order. My article "How to destroy an invention - the patent office way" appeared in DNA Newspaper today. The same can be read in full at The Vanishing Point
Patent Agents are a unique breed. They are expected to know something about both law and science. As many gear up to take the patent agent examination on 23rd January 2010, here is a little piece titled "The Curious Case of Patent Agents" which appeared in today's The Hindu. The article raises certain questions on the current system of selecting patent agents based on a two paper examination followed by viva-voce. The full article can be read at The Vanishing Point
Professor at the University of Leeds will be speaking at the Madras Law College (adjacent to Madras High Court) on "Patents, Traditional Knowledge and the Pharmaceutical Industry" on Thursday, 21st January, 2010 at 10:00 am. Those interested can assemble at the Law College campus by 9:45 am. I hope to be there too.
Pharma Patents blog is changing for the better. We are moving to a new blog, The Vanishing Point
, a place like the point in perspective drawing
where parallels appear to meet. The Vanishing Point Blog discusses issues at the intersection of law and technology. This will give us the room to discuss issues beyond patents and pharmaceuticals which affect technology-based enterprises. Some of the popular posts of pharma patents have been re-posted there. Please subscribe to The Vanishing Point here
and continue to get email updates on pharmaceutical patents, law and technology issues and much more.
More Recent Articles